Corporate
Description
  • Value proposition

    Pioneering Diagnostics

    Pioneering Diagnostics

    A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.

    In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.

    bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

    Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

    bioMérieux is listed on the Euronext Paris stock market.

    Symbol: BIM – ISIN Code: FR0013280286
    Reuters: BIOX.PA/Bloomberg: BIM.FP


    in vitro diagnostics, infectious diseases, reagents, automated instruments, medical analysis, cosmetics, pharmaceutical, industries, healthcare associated infections, molecular biology, microbiology, immunoassays, antimicrobial stewardship, rapid diagnostics, food safety, veterinary diagnostics, blood bank, and sepsis

  • Original language

    Pioneering Diagnostics

    Pioneering Diagnostics

    A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.

    In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.

    bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

    Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

    bioMérieux is listed on the Euronext Paris stock market.

    Symbol: BIM – ISIN Code: FR0013280286
    Reuters: BIOX.PA/Bloomberg: BIM.FP

Entity interactions BETA
Entity TypeTweets Articles
Fromont Briens Fromont Briens
Law Practice, legaltech
Not capitalistic
Not partnership
Event

23 Mar 2021


Vignovin Vignovin
foodtech, Beverage Manufacturing
Not capitalistic
Not partnership
Event

1 Dec 2021


TransPerfect TransPerfect
Translation and Localization
Other

11 Jun 2020


Photonics Bretagne - Photonics Innovation Hub Photonics Bretagne - Photonics Innovation Hub
Research Services
Other

4 Jun 2018


International Association for Food Protection International Association for Food Protection
foodtech, Food and Beverage Services
Other

1 Aug 2022

13 Aug 2024



FoodNavigator FoodNavigator
Book and Periodical Publishing
Other

15 Jun 2018


Business Cool Business Cool
edtech, Online Audio and Video Media
Other

19 Aug 2021


The UK Sepsis Trust The UK Sepsis Trust
fintech, edtech, healthtech, Hospitals and Health Care
Other

13 Sep 2021

1 Sep 2023



Excellence industrielle Saint-Laurent Excellence industrielle Saint-Laurent
greentech, Business Consulting and Services
Other

5 Jul 2021


ResearchGate ResearchGate
edtech, deeptech, Software Development
Not capitalistic
Not partnership
Event

13 Oct 2021


Radars
Loading...